The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

CompletedOBSERVATIONAL
Enrollment

51,955

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

November 28, 2022

Conditions
Alopecia AreataDepressive EpisodeRecurrent Depressive DisorderAnxiety DisordersAtopic DermatitisAllergic RhinitisAsthmaCrohn DiseaseUlcerative ColitisPernicious AnemiaType 1 DiabetesHashimoto ThyroiditisGraves DiseaseRheumatoid ArthritisPsoriatic ArthritisAnkylosing SpondylitisSystemic Lupus ErythematosusPolymyalgia RheumaticaSjogren's SyndromePsoriasisVitiligoMultiple SclerosisCeliac DiseaseUpper Respiratory Tract InfectionInfluenzaLower Resp Tract InfectionAcute BronchitisPneumoniaGastrointestinal InfectionSkin InfectionUrinary Tract InfectionsGenital InfectionHerpes ZosterHerpes SimplexInfectionInfection Viral
Interventions
OTHER

Exposure of interest (studies 2 & 3).

Common mental health conditions consist of depressive episodes, recurrent depressive disorder and anxiety disorder Atopic conditions consist of Atopic dermatitis, allergic rhinitis, asthma Autoimmune conditions consist of Crohn's disease, ulcerative colitis, Coeliac disease, Pernicious anaemia, Type 1 diabetes, Hashimoto's thyroiditis, Grave's disease, Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Systemic lupus erythematosus, polymyalgia rheumatica, Sjögren's syndrome, Psoriasis, vitiligo, Multiple sclerosis

Trial Locations (1)

WC1X 8QT

Momentum Data Ltd, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

University of Surrey

OTHER

collaborator

University of Oxford

OTHER

lead

Momentum Data

INDUSTRY

NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata | Biotech Hunter | Biotech Hunter